HCTIHCTIHealthcare · Health Information Services

HCTI Stock Forecast: Healthcare Triangle, Inc. Price Predictions for 2026-2027

Last close, 31 July 2026
$1.10

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 20 of 100 as at 1 Aug 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$2.2M
Ticker Nerd rank
20 / 100
Median analyst target
$5.00
Analysts covering
0
Ticker Nerd rank

HCTI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Healthcare Triangle, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
20 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
99
Growth
71
Revisions
62
Volatility
38
Quality
29
Accruals
18
Value
11
Issuance
4
Momentum
1

Size (99): Smaller than most of the companies we track.

Momentum (1): The shares have been drifting down relative to others.

The rank is the raw material. Whether the rules would actually own Healthcare Triangle, Inc. — and when they’d sell — is the membership.

Wall Street

HCTI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on HCTI, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
28 Sept 2022EF HuttonMaintainsBuy$4.00$2.00
14 Mar 2022EF HuttonInitiatesBuy$4.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

HCTI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
0
Fundamentals

Healthcare Triangle, Inc. (HCTI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
0.0×

Cheaper than 74% of US stocks

Price / sales
0.1×

Cheaper than 96% of US stocks

Price / book
0.1×

Cheaper than 91% of US stocks

EV / EBITDA
−3.2×

Cheaper than 76% of US stocks

Growth & margins
Revenue growth (YoY)
166.1%

Higher than 96% of US stocks

Earnings growth (YoY)
166.1%

Higher than 90% of US stocks

Gross margin
24.3%

Higher than 29% of US stocks

Operating margin
−36.8%

Higher than 19% of US stocks

Net margin
−69.7%

Higher than 8% of US stocks

Returns & dividend
Return on equity
−45.6%

Higher than 22% of US stocks

Return on assets
−16.3%

Higher than 22% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

HCTI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
HCTIHealthcare Triangle, Inc.$2.2M
20
MNDRMobile-health Network Solutions$2.2M
14
ZCMDZhongchao, Inc.$1.3M
22
VSEEVSee Health, Inc.$4.4M
31
ACONAclarion, Inc.$5.5M
23
MGRXMangoceuticals, Inc.$9.6M
25
BFRGBullFrog AI Holdings, Inc.$10.2M
29
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HCTI appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest HCTI news & analysis

Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets

PRNewsWire · 29 July 2026positive

Healthcare Triangle, Inc. (HCTI) has signed a non-binding Letter of Intent to acquire 51% of CosmoInnovations, a move that will bring 27 granted international patents and 61 pending applications into its portfolio and expand the company into MedTech and consumer-health markets.

Why it matters — This acquisition would mark HCTI's entry into high-growth proprietary MedTech and consumer-health markets with a substantial patent portfolio and a commercial pipeline that could significantly broaden its revenue base.

Healthcare Triangle Completes Share Issuances Relating to Legacy M&A Transactions, Strengthening Compliance With Nasdaq's New $5 Million Market Value Listing Standard

PRNewsWire · 29 July 2026positive

Healthcare Triangle completed the issuance of 12,546,540 shares of common stock on July 24, 2026, relating to its acquisition of Teyame AI LLC and a Share Exchange Agreement with SecureKloud Technologies Ltd., increasing total shares outstanding to 14,644,322.

Why it matters — The share issuance provides added cushion under Nasdaq's newly effective $5 million Market Value of Listed Securities requirement, strengthening HCTI's compliance with continued listing standards.

FAQ

Frequently asked questions about HCTI stock

How does Ticker Nerd's model rank HCTI?

As at 1 Aug 2026, Healthcare Triangle, Inc. ranks 20 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (99 of 100).

What is the HCTI stock forecast for 2030?

No analyst covering Healthcare Triangle, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HCTI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $5 to $5 over the next 12 months.

What does Healthcare Triangle, Inc. do?

Healthcare Triangle Inc. is a healthcare information technology company specializing in digital transformation solutions for healthcare and life sciences organizations.

What is the latest news on HCTI?

The most recent item we track (PRNewsWire, 29 July 2026): "Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets". Healthcare Triangle, Inc. (HCTI) has signed a non-binding Letter of Intent to acquire 51% of CosmoInnovations, a move that will bring 27 granted international patents and 61 pending applications into its portfolio and expand the company into MedTech and consumer-health markets.

Company

About Healthcare Triangle, Inc.

Healthcare Triangle Inc. is a healthcare information technology company specializing in digital transformation solutions for healthcare and life sciences organizations. It provides HITRUST-certified cloud platforms like CloudEz™ and DataEz™, along with data lifecycle management, analytics, security, compliance, and interoperability services to support hospitals, health systems, payers, and pharma companies in optimizing clinical and business performance. Through its subsidiary QuantumNexis Inc., the company delivers AI-powered hospital information systems such as Ezovion, clinically validated digital mental health solutions via Ziloy.ai, and population-scale care delivery platforms. These offerings emphasize national interoperability using openEHR standards, AI-driven automation, digital therapeutics, telehealth, and patient engagement tools, with recent expansions into GCC countries like the UAE and partnerships in Malaysia for in-app mental health support. Healthcare Triangle Inc., founded in Pleasanton, California, enables organizations to adopt new technologies, enhance data utilization, and achieve business agility in regulated environments.

CEO Mr. Anand Kumar · 41 employees · United States · https://www.healthcaretriangle.com